InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-36.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Lian Brian, Chairman & CEO. Director active across 1 company, notably Viking Therapeutics, Inc.. Cumulatively, 21 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €2.9m. Activity tracked since 28 September 2021. The latest transaction was disclosed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations21 total
48,333 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093793:0
92,800 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002487:0
166,130 shares@ US$7.7720.0% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-108576:0
1,000 shares@ US$7.770.1% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-099982:0
112,870 shares@ US$7.7713.7% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-098803:0
41,000 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088544:0
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005117:0
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004233:0
45,000 shares@ US$29.9021.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003068:0
49,079 shares@ US$1.231.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003010:0
85,000 shares@ US$1.231.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-002512:0
35,000 shares@ US$1.230.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-002458:0
150,000 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000931:0
45,000 shares@ US$22.4515.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-026356:0
35,000 shares@ US$21.4511.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-025277:0
125,000 shares@ US$2.154.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024724:0
54,336 shares@ US$1.881.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024228:0
115,852 shares@ US$1.232.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022400:0
121,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001340:0
36,319 shares@ US$4.880.0044% mcap50.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001986:0
55,500 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058253:0
21 of 21 declarations
About Lian Brian
Brian Lian is the President and Chief Executive Officer of Viking Therapeutics, Inc. He leads the company in its efforts to develop innovative treatments in the healthcare sector. Under his leadership, Viking Therapeutics focuses on research and development of therapeutic solutions that address unmet patient needs. Brian is recognized for his strategic vision and commitment to innovation in the biopharmaceutical industry.
